Dr. Philip Parks joined Exact Sciences in 2017 as the Head of Medical Affairs and member of the leadership team. Dr. Parks also has more than 17 years of clinical, research and development, corporate medicine, and managed care experience. He maintains academic appointments at Harvard Medical School and the Harvard T.H. Chan School of Public Health. His clinical training is in preventive medicine and he received his medical degree and graduate degrees from Tulane University School of Medicine, Tulane School of Public Health & Tropical Medicine, and the Harvard T.H. Chan School of Public Health.
Clinical Dx Showcase: Exact Sciences
Exact Sciences is committed to helping win the war on cancer through early detection.
Exact Sciences & Cologuard: Winning the War on Cancer through Early Detection
The presentation will provide an overview of Exact Sciences Corporation, its first product – Cologuard, and research & development pipeline. The brief talk will highlight that Cologuard is the first and only molecular diagnostic to proceed through parallel approval by FDA and CMS. In addition, Cologuard is the first and only FDA approved multi-target stool DNA test. Finally, the presentation will provide an overview of Cologuard’s clinical performance and utilization to date.